Atlas Venture Fund Ix, L.p. - Net Worth and Insider Trading
Atlas Venture Fund Ix, L.p. Net Worth
The estimated net worth of Atlas Venture Fund Ix, L.p. is at least $71 Million dollars as of 2024-11-13. Atlas Venture Fund Ix, L.p. is the 10% Owner of Intellia Therapeutics Inc and owns about 3,579,788 shares of Intellia Therapeutics Inc (NTLA) stock worth over $60 Million. Atlas Venture Fund Ix, L.p. is the 10% Owner of Cogent Biosciences Inc and owns about 840,384 shares of Cogent Biosciences Inc (COGT) stock worth over $9 Million. Atlas Venture Fund Ix, L.p. is also the 10% Owner of Surface Oncology Inc and owns about 2,945,453 shares of Surface Oncology Inc (SURF) stock worth over $3 Million. Details can be seen in Atlas Venture Fund Ix, L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Atlas Venture Fund Ix, L.p. has not made any transactions after 2020-12-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Atlas Venture Fund Ix, L.p.
Atlas Venture Fund Ix, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Atlas Venture Fund Ix, L.p. owns 5 companies in total, including Surface Oncology Inc (SURF) , Cogent Biosciences Inc (COGT) , and Spero Therapeutics Inc (SPRO) among others .
Click here to see the complete history of Atlas Venture Fund Ix, L.p.’s form 4 insider trades.
Insider Ownership Summary of Atlas Venture Fund Ix, L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SURF | Surface Oncology Inc | 2020-12-17 | 10 percent owner |
| COGT | Cogent Biosciences Inc | 2018-04-03 | 10 percent owner |
| SPRO | Spero Therapeutics Inc | 2017-11-01 | 10 percent owner |
 | | 2017-08-28 | 10 percent owner |
| | 2017-07-11 | 10 percent owner |
Atlas Venture Fund Ix, L.p. Latest Holdings Summary
Atlas Venture Fund Ix, L.p. currently owns a total of 3 stocks. Among these stocks, Atlas Venture Fund Ix, L.p. owns 3,579,788 shares of Intellia Therapeutics Inc (NTLA) as of July 11, 2017, with a value of $60 Million and a weighting of 83.39%. Atlas Venture Fund Ix, L.p. owns 840,384 shares of Cogent Biosciences Inc (COGT) as of April 3, 2018, with a value of $9 Million and a weighting of 12.2%. Atlas Venture Fund Ix, L.p. also owns 2,945,453 shares of Surface Oncology Inc (SURF) as of December 17, 2020, with a value of $3 Million and a weighting of 4.41%.
Latest Holdings of Atlas Venture Fund Ix, L.p.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NTLA | Intellia Therapeutics Inc | 2017-07-11 | 3,579,788 | 16.65 | 59,603,470 |
| COGT | Cogent Biosciences Inc | 2018-04-03 | 840,384 | 10.38 | 8,723,186 |
| SURF | Surface Oncology Inc | 2020-12-17 | 2,945,453 | 1.07 | 3,151,635 |
Holding Weightings of Atlas Venture Fund Ix, L.p.
Atlas Venture Fund Ix, L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Atlas Venture Fund Ix, L.p. has made a total of 0 transactions in Intellia Therapeutics Inc (NTLA) over the past 5 years. The most-recent trade in Intellia Therapeutics Inc is the sale of 150,000 shares on July 11, 2017, which brought Atlas Venture Fund Ix, L.p. around $2 Million.
According to the SEC Form 4 filings, Atlas Venture Fund Ix, L.p. has made a total of 0 transactions in Cogent Biosciences Inc (COGT) over the past 5 years. The most-recent trade in Cogent Biosciences Inc is the acquisition of 23,513 shares on April 3, 2018, which cost Atlas Venture Fund Ix, L.p. around $1 Million.
According to the SEC Form 4 filings, Atlas Venture Fund Ix, L.p. has made a total of 2 transactions in Surface Oncology Inc (SURF) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Surface Oncology Inc is the sale of 1,700,000 shares on December 17, 2020, which brought Atlas Venture Fund Ix, L.p. around $31 Million.
Insider Trading History of Atlas Venture Fund Ix, L.p.
- 1
Atlas Venture Fund Ix, L.p. Trading Performance
GuruFocus tracks the stock performance after each of Atlas Venture Fund Ix, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Atlas Venture Fund Ix, L.p. is 22.08%. GuruFocus also compares Atlas Venture Fund Ix, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Atlas Venture Fund Ix, L.p. within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Atlas Venture Fund Ix, L.p.'s insider trading performs compared to the benchmark.
Performance of Atlas Venture Fund Ix, L.p.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 9.54 | | | | | |
| Relative Return to S&P 500(%) | 8.07 | | | | | |
Atlas Venture Fund Ix, L.p. Ownership Network
Ownership Network List of Atlas Venture Fund Ix, L.p.
Ownership Network Relation of Atlas Venture Fund Ix, L.p.
Atlas Venture Fund Ix, L.p. Owned Company Details
What does Surface Oncology Inc do?
Who are the key executives at Surface Oncology Inc?
Atlas Venture Fund Ix, L.p. is the 10 percent owner of Surface Oncology Inc. Other key executives at Surface Oncology Inc include Deputy GC Chandra Adams , Chief Medical Officer Alison Oneill , and See Remarks Jessica Fees .
Surface Oncology Inc (SURF) Insider Trades Summary
Over the past 18 months, Atlas Venture Fund Ix, L.p. made no insider transaction in Surface Oncology Inc (SURF). Other recent insider transactions involving Surface Oncology Inc (SURF) include a net sale of 16,713 shares made by Robert W. Ross , a net sale of 9,434 shares made by Jessica Fees , and a net sale of 7,042 shares made by Alison Oneill .
In summary, during the past 3 months, insiders sold 0 shares of Surface Oncology Inc (SURF) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 37,090 shares of Surface Oncology Inc (SURF) were sold and 0 shares were bought by its insiders, resulting in a net sale of 37,090 shares.
Surface Oncology Inc (SURF)'s detailed insider trading history can be found in Insider Trading Tracker table.
Surface Oncology Inc Insider Transactions
Atlas Venture Fund Ix, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Atlas Venture Fund Ix, L.p.. You might contact Atlas Venture Fund Ix, L.p. via mailing address: 56 Wareham Street, Floor 3, Boston Ma 02118.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
